These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29735634)

  • 1. Evaluation of Sildenafil and Tadalafil for Reversing Constriction of Fetal Arteries in a Human Placenta Perfusion Model.
    Walton RB; Reed LC; Estrada SM; Schmiedecke SS; Villazana-Kretzer DL; Napolitano PG; Ieronimakis N
    Hypertension; 2018 Jul; 72(1):167-176. PubMed ID: 29735634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sildenafil treatment in a nonsevere hypertensive murine model lowers blood pressure without reducing fetal growth.
    Roberts RP; Refuerzo JS; Ferrari F; Ontiveros AE; Tamayo EH; Sibai BM; Blackwell SC; Longo M
    Am J Obstet Gynecol; 2016 Sep; 215(3):386.e1-8. PubMed ID: 27177526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase-5 inhibitors tadalafil and sildenafil potentiate nitrergic-nerve mediated relaxations in the bladder vasculature.
    Nilsson D; Chess-Williams R; Sellers D
    Eur J Pharmacol; 2023 Dec; 960():176152. PubMed ID: 37925131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast Cancer Resistance Protein Limits Fetal Transfer of Tadalafil in Mice.
    Nishimura T; Ishii M; Tanaka H; Noguchi S; Ikeda T; Tomi M
    J Pharm Sci; 2024 Feb; 113(2):486-492. PubMed ID: 37981232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental effects and transfer of sildenafil in healthy and preeclamptic conditions.
    Hitzerd E; Broekhuizen M; Mirabito Colafella KM; Glisic M; de Vries R; Koch BCP; de Raaf MA; Merkus D; Schoenmakers S; Reiss IKM; Danser AHJ; Simons SHP
    EBioMedicine; 2019 Jul; 45():447-455. PubMed ID: 31204276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.
    Groom KM; David AL
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S829-S840. PubMed ID: 29229321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between transdermal nitroglycerin and sildenafil citrate in intrauterine growth restriction: effects on uterine, umbilical and fetal middle cerebral artery pulsatility indices.
    Trapani A; Gonçalves LF; Trapani TF; Franco MJ; Galluzzo RN; Pires MM
    Ultrasound Obstet Gynecol; 2016 Jul; 48(1):61-5. PubMed ID: 26279411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental growth factor as a predictor of the efficacy of tadalafil treatment for fetal growth restriction.
    Kubo-Kaneda M; Tanaka H; Maki S; Nii M; Umekawa T; Osato K; Kamimoto Y; Kondo E; Ikeda T
    J Matern Fetal Neonatal Med; 2019 Sep; 32(17):2879-2882. PubMed ID: 29580120
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of sildenafil on maternal hemodynamics in pregnancies complicated by severe early-onset fetal growth restriction: planned subgroup analysis from a multicenter randomized placebo-controlled double-blind trial.
    Khalil A; Sharp A; Cornforth C; Jackson R; Mousa H; Stock S; Harrold J; Turner MA; Kenny LC; Baker PN; Johnstone ED; Von Dadelszen P; Magee L; Papageorghiou AT; Alfirevic Z
    Ultrasound Obstet Gynecol; 2020 Feb; 55(2):198-209. PubMed ID: 31432556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal tadalafil treatment does not increase uterine artery blood flow or oxygen delivery in the pregnant ewe.
    Darby JRT; Flouri D; Cho SKS; Williams GK; Holman SL; Meakin AS; Wiese MD; David AL; Macgowan CK; Seed M; Melbourne A; Morrison JL
    Exp Physiol; 2024 Jun; 109(6):980-991. PubMed ID: 38606906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment using tadalafil for severe pre-eclampsia with fetal growth restriction.
    Tanaka H; Kubo M; Nii M; Maki S; Umekawa T; Ikeda T
    J Obstet Gynaecol Res; 2017 Jul; 43(7):1205-1208. PubMed ID: 28503744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sildenafil citrate increases fetal weight in a mouse model of fetal growth restriction with a normal vascular phenotype.
    Dilworth MR; Andersson I; Renshall LJ; Cowley E; Baker P; Greenwood S; Sibley CP; Wareing M
    PLoS One; 2013; 8(10):e77748. PubMed ID: 24204949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utero-placental perfusion Doppler indices in growth restricted fetuses: effect of sildenafil citrate.
    El-Sayed MA; Saleh SA; Maher MA; Khidre AM
    J Matern Fetal Neonatal Med; 2018 Apr; 31(8):1045-1050. PubMed ID: 28345432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia.
    Downing JW; Ramasubramanian R; Johnson RF; Minzter BH; Paschall RL; Sundell HW; Engelhardt B; Lewis R
    Med Hypotheses; 2004; 63(6):1057-64. PubMed ID: 15504576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superior vasodilation of human pulmonary vessels by vardenafil compared with tadalafil and sildenafil: additive effects of bosentan.
    Ried M; Neu R; Lehle K; Großer C; Szöke T; Lang G; Hofmann HS; Hoenicka M
    Interact Cardiovasc Thorac Surg; 2017 Aug; 25(2):254-259. PubMed ID: 28486684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil crosses the placenta at therapeutic levels in a dually perfused human cotyledon model.
    Russo FM; Conings S; Allegaert K; Van Mieghem T; Toelen J; Van Calsteren K; Annaert P; Deprest J
    Am J Obstet Gynecol; 2018 Dec; 219(6):619.e1-619.e10. PubMed ID: 30194048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placenta-anchored tadalafil liposomes rescues intrauterine growth restriction through continuous placental blood perfusion improvement.
    Tang M; Xin Y; Zhao Y; Zhang X; Zhang M; Sun D; Zhu X; Yao Y; Fei W; Zheng C
    J Control Release; 2024 Apr; 368():466-480. PubMed ID: 38452820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed statistical analysis plan for the Dutch STRIDER (Sildenafil TheRapy In Dismal prognosis Early-onset fetal growth Restriction) randomised clinical trial on sildenafil versus placebo for pregnant women with severe early onset fetal growth restriction.
    Pels A; Jakobsen JC; Ganzevoort W; Naaktgeboren CA; Onland W; van Wassenaer-Leemhuis AG; Gluud C
    Trials; 2019 Jan; 20(1):42. PubMed ID: 30635020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of sildenafil citrate in cases of intrauterine growth restriction (IUGR); a prospective trial.
    Maged M; Wageh A; Shams M; Elmetwally A
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):483-486. PubMed ID: 30122565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating maternal hyperglycemic exposure and fetal placental arterial dysfunction in a dual cotyledon, dual perfusion model.
    Reed LC; Estrada SM; Walton RB; Napolitano PG; Ieronimakis N
    Placenta; 2018 Sep; 69():109-116. PubMed ID: 30213479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.